San Francisco, 3 December 2018: The global ophthalmic lasers market is
anticipated to reach USD 1.6 billion by 2025, according to a new report by
Grand View Research, Inc. Ophthalmic disorders are rising significantly on a
global level. This rise in the prevalence rate has led to high growth of
ophthalmic lasers market.
According to American Academy of Ophthalmology
2014 statistics, nearly 4.2 million people in the U.S. are visually impaired.
Huge number of people suffering from visual impairment are likely to heighten
the demand for ophthalmic lasers in the coming years.
Vision loss is a serious problem among people
suffering from glaucoma, cataract, age-related macular degeneration (AMD), and
diabetic retinopathy. This commonly occurs among the geriatric population.
American Academy of Ophthalmology stated that, around 1.3 million U.S.
population are blind. Hence, in order to minimize such huge rate of vision
loss, there is a high need for the application of ophthalmic laser technology.
Geriatric population are the primary target
for the market. Majority of the chronic ophthalmic disorders, for instance,
cataract and AMD occur among this group of population. However, refractive
errors are also very common among the young people. Thus, growing number of
victims of chronic eye diseases has led to an expected growth of the market.
Access
Research Report of Ophthalmic Lasers
Market @ www.grandviewresearch.com/industry-analysis/ophthalmic-lasers-market
Further key findings from the study suggest:
· In 2016, femtosecond lasers dominated the
market due to rising prevalence of refractive errors among both geriatric and
young population
· Amongst the application segment, refractive
error corrections held the largest market share in 2016 due to large number of
surgeries conducted for refractive errors
· Cataract removal is anticipated to show
lucrative growth over the forecast period owing to the rising prevalence of
cataract removal surgeries among the geriatric people
· In 2016, hospitals contributed towards the
largest revenue share owing to the emergence of large number of hospitals in
developing economies
· North America dominated the market in 2016
due to rising prevalence of ophthalmic disorders in this region
· Asia Pacific is expected to show lucrative
growth over the forecast period owing to the increase in awareness levels among
people in developing countries about various treatments for chronic eye
disorders
· Few major companies include Carl Zeiss
Meditec AG, Abbott Medical Optics, Inc., Alcon Laboratories, Inc., Ellex
Medical Lasers Limited, Lumenis, and Bausch & Lomb Incorporated.
Browse more reports of this category by Grand View
Research at: www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the
ophthalmic lasers market on the basis of product, application, end-use, and
region:
Ophthalmic Lasers Product Outlook (Revenue,
USD Million, 2014 - 2025)
·
Diode Lasers
·
Femtosecond Lasers
·
Excimer Lasers
·
Nd:YAG lasers
·
SLT Lasers
·
Others
Ophthalmic Lasers Application Outlook
(Revenue, USD Million, 2014 - 2025)
·
Glaucoma
·
Cataract Removal
·
Refractive Error Corrections
·
Diabetic Retinopathy
·
AMD
·
Others
Ophthalmic Lasers End-use Outlook (Revenue,
USD Million, 2014 - 2025)
·
Hospitals
·
Ambulatory Surgical Centers
·
Ophthalmic Clinics
Ophthalmic Lasers Regional Outlook
(Revenue, USD Million, 2014 - 2025)
·
North America
·
Europe
·
Asia Pacific
·
Latin America
·
MEA
Access Press Release of
Ophthalmic Lasers Market@ www.grandviewresearch.com/press-release/global-ophthalmic-lasers-market
About
Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business decisions,
we offer market intelligence studies ensuring relevant and fact-based research
across a range of industries, from technology to chemicals, materials and
healthcare.
No comments:
Post a Comment